glp 1 and sglt2 Perspectives in weight control in diabetes – inhibitors GLP-1–glucagon dual agonism APhA 2025: GLP-1 Receptor Agonists
Description
it also contains a compound that mimics a second gut hormone, GIP (glucose-dependent insulinotropic polypeptide)
Pair these with daily observations for a fuller understanding of your health journey
The trade-off
You are sensitive to nausea on semaglutide
Patients with diabetes taking semaglutide should be particularly vigilant, as they may experience atypical or less pronounced symptoms due to diabetic neuropathy affecting sensory perception
